嗅觉和听觉功能障碍对老年人认知障碍的附加效应
Meiko Kitazawa1, Yuki Shirakura2, Yuka Ohaku2
1Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
The Laryngoscope
|December 13, 2025
概括
多感官障碍,特别是综合的嗅觉和听觉功能障碍,与老年人的认知障碍有显著联系. 解决这两种感官功能障碍对于理解和管理认知衰退至关重要.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 感官科学 感官科学
背景情况:
- 认知障碍在老年人群中越来越令人担忧.
- 听力和嗅觉障碍与认知能力下降有关.
- 多感官障碍,即多个感官的同时功能障碍,在老年人中很普遍.
研究的目的:
- 研究认知障碍与老年人嗅觉和听觉功能障碍的同时发生之间的关联.
- 为了确定综合感官缺陷是否具有较高的认知障碍风险.
主要方法:
- 一项以人口为基础的调查招募了505名65-84岁的参与者.
- 用日本快速轻度认知障碍屏幕 (Qmci-J) 评估认知功能.
- 嗅觉和听觉功能分别使用开放本质测试和纯色音量测试进行评估,并分为正常,中度或严重.
主要成果:
- 近一半 (44.6%) 的参与者表现出认知障碍.
- 严重的嗅觉或听觉功能障碍,再加上其他意义上的至少中度功能障碍,与认知障碍有显著的关联.
- 最强的关联是在两种感官严重功能障碍的个体中发现的 (PR=1.90),表明了附加效应.
结论:
- 嗅觉和听觉功能障碍与老年人认知障碍相加相关.
- 这些发现强调了评估和考虑多感官障碍在衰老认知健康的背景下的重要性.
- 对综合感官缺陷的早期检测和干预可能在缓解认知衰退方面发挥作用.
相关概念视频
Olfaction
48.0K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
48.0K
Olfactory Receptors: Location and Structure
11.1K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
11.1K
Cognitive Development During Adulthood
745
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
745
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
512
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
512
Interference and Decay
399
Forgetting is a complex cognitive phenomenon influenced by several factors, among which interference and decay are particularly prominent. These processes explain why individuals often struggle to retrieve specific information from memory, leading to lapses in recall that can be observed in everyday situations.
Interference occurs when competing memories hinder the retrieval of particular information. It can be classified into two types: proactive and retroactive interference. Proactive...
Interference occurs when competing memories hinder the retrieval of particular information. It can be classified into two types: proactive and retroactive interference. Proactive...
399
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


